Concepedia

Azra Mujić-Delić

AM

Statistics

Publications

4

Citations

332

H-Index

4

Active since

2012

Affiliations

Vrije Universiteit Amsterdam(Current)

Ablynx (Belgium)

Azra Mujić-Delić is an author at Vrije Universiteit Amsterdam specializing in ligand binding, pharmacology, and receptor-ligand interactions.

Publications per year

2012–2016

4

Publications

4

Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growth in Vivo

David Maussang, Azra Mujić-Delić, Francis J. Descamps et al. · Journal of Biological Chemistry · 2013 · 143 citations · Full text

Medicine, Oncology, Pharmacology +17

Synthesis, modeling and functional activity of substituted styrene-amides as small-molecule CXCR7 agonists

Maikel Wijtmans, David Maussang, Francesco Sirci et al. · European Journal of Medicinal Chemistry · 2012 · 70 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Human cytomegalovirus encoded chemokine receptor US28 activates the HIF-1α/PKM2 axis in glioblastoma cells

Raymond H. de Wit, Azra Mujić-Delić, Jeffrey R. van Senten et al. · Oncotarget · 2016 · 69 citations · Full text

Medicine, Cancer Biology, Oncology +17

Neutralizing Nanobodies Targeting Diverse Chemokines Effectively Inhibit Chemokine Function

Christophe Blanchetot, Dennis Verzijl, Azra Mujić-Delić et al. · Journal of Biological Chemistry · 2013 · 50 citations · Full text

Life Sciences, Immunology, Pharmacology +17

1–4 of 4